Actively Recruiting
Developing Patient-Derived Xenografts to Understand Cancer Disparities in Minority Populations by University of California Davis
Led by University of California, Davis · Updated on 2026-08-20
500
Participants Needed
2
Research Sites
26 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying patient-derived cancer xenografts PDXs to address cancer health and treatment disparities affecting racial and ethnic minorities. This observational trial aims to develop and characterize over 200 PDXs, especially focusing on gastric, liver, bladder, and lung cancers with a majority from HispanicLatino Americans, African Americans, and Asian AmericanNative HawaiiansPacific Islanders. The goal is to understand genetic differences and treatment responses among these groups to improve precision cancer medicine. Participants provide tumor tissue samples collected during their standard care biopsies or surgeries to create these PDX models. Additional samples such as blood, saliva, and urine may also be collected to analyze DNA abnormalities in both cancer and noncancer cells. The research includes testing single drugs and combinations on these PDXs, collaborating with national centers to explore biological factors behind cancer disparities. Throughout the study, participants undergo sample collection during their regular cancer treatment without additional interventions. Researchers measure and characterize the PDX models over up to four years. No experimental treatments are given to participants, and the study focuses on biospecimen collection to support preclinical research aimed at guiding future therapies. Participation duration varies according to patient care and sample collection opportunities.
CONDITIONS
Brief Title
Patient-Derived Xenografts to Reduce Cancer Health Disparities
Research Team
A
Asst. Clinical Research Coordinator
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here